Search Results 131-140 of 16615 for primary sclerosing cholangitis
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...
Explore our research on primary sclerosing cholangitis and polycystic liver diseases, including our work to develop and test drugs that selectively kill ...
Mayo researchers were among the first to identify metabolic dysfunction-associated steatotic liver disease and primary sclerosing cholangitis. Mayo ...
... Primary Sclerosing Cholangitis. Transplantation. 2017 Aug; 101 (8):1859-1866 ... Recall processes for biliary cytology in primary sclerosing cholangitis.
The purpose of this study is to evaluate the safety and efficacy of Saroglitazar Magnesium in participants with Primary Biliary Cholangitis. Participation ...
The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ...
In the following model, short-term survival probability of a patient with primary biliary cholangitis is estimated based on repeated observation. Please ...
Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. Clin Transl ...
As many as 10 percent of patents with this cancer have a condition known as primary sclerosing cholangitis (PSC), a chronic inflammatory disease of the large ...
... Primary Biliary Cirrhosis (AIH-PBC), overlap AIH with Primary Sclerosing Cholangitis (AIH-PSC), and drug-induced autoimmune-like hepatitis (DIAIH).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.